Elemental Machines Launches New Product to Enhance Clean Room Alerting and
Precision BioSciences to Participate in Upcoming November Investor Conferen
AN2 Therapeutics to Participate at Upcoming Investor Conferences
Medidata and Bioforum Bolster Decade-Long Relationship to Advance Clinical
Healx announces agreement with Sanofi to seek new rare disease indications
Attivare Therapeutics Appoints David Sherris, Ph.D. as President, CEO, and
ImmunoPrecise to Host TECHDAY: Cutting-Edge AI and Biologics Innovation
Arrowhead Pharmaceuticals Launches New Disease Awareness Campaign, ‘We’
ASP Japan G.K. Certified as a Great Place To Work® for Third Consecutive Y
Precision BioSciences to Report Third Quarter Results on November 4, 2024
PopVax Announces 1.15 Million USD in Funding from the Bill & Melinda Gates
Precision BioSciences to Host Virtual Investor Event Highlighting PBGENE-HB
ImmunoPrecise Advances Anti-Aging Research with Mayo Clinic Study, Poised t
Spectrum Healthcare Partners Leverages Pramana’s AI-Enabled Scanners to B
Precision BioSciences Receives First Approval of Clinical Trial Application
ATCC Receives Grant from NIH to Build New Biomanufacturing Suite at its Man
Viz.ai Expands into Lung Disease to Accelerate Diagnosis and Care for Patie
ImmunoPrecise Antibodies to Participate at the AI Driven Drug Discovery Sum
Agilent Revolutionizes HPLC with the Launch of the Agilent Infinity III LC
Precision BioSciences to Present at the European Society of Gene & Cell The